X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tumor-induced osteomalacia (358) 358
index medicus (287) 287
humans (262) 262
oncogenic osteomalacia (170) 170
male (142) 142
hypophosphatemia (134) 134
female (121) 121
endocrinology & metabolism (114) 114
fgf23 (101) 101
middle aged (100) 100
osteomalacia (94) 94
fibroblast growth factor 23 (93) 93
rickets (86) 86
adult (82) 82
fgf-23 (79) 79
animals (69) 69
fibroblast growth factors - blood (69) 69
osteomalacia - etiology (68) 68
x-linked hypophosphatemia (66) 66
fibroblast growth factor-23 (58) 58
tumors (58) 58
diagnosis (51) 51
vitamin d (49) 49
fibroblast growth factors (48) 48
phosphate (48) 48
phosphates (48) 48
phosphate homeostasis (47) 47
aged (46) 46
mice (46) 46
fibroblast-growth-factor-23 (45) 45
hypophosphatemia - etiology (45) 45
phosphates - metabolism (45) 45
urology & nephrology (45) 45
fibroblast growth factors - metabolism (44) 44
phosphaturic mesenchymal tumor (43) 43
vitamin-d metabolism (43) 43
medicine, general & internal (41) 41
parathyroid-hormone (40) 40
bone (37) 37
homeostasis (35) 35
medicine & public health (35) 35
adolescent (34) 34
abridged index medicus (33) 33
care and treatment (33) 33
dominant hypophosphatemic rickets (33) 33
fibroblast growth factors - genetics (33) 33
orthopedics (33) 33
phosphates - blood (33) 33
localization (32) 32
osteomalacia - diagnosis (32) 32
mesenchymal tumors (31) 31
hypophosphatemic rickets (29) 29
chronic kidney-disease (27) 27
stem cells (27) 27
diagnosis, differential (26) 26
surgery (26) 26
parathyroid hormone - blood (25) 25
radiology, nuclear medicine & medical imaging (25) 25
research (25) 25
child (24) 24
fibroblast growth factors - physiology (24) 24
medicine, research & experimental (24) 24
parathyroid hormone (24) 24
risk factors (24) 24
bone neoplasms - complications (23) 23
phex (23) 23
physiological aspects (23) 23
vitamin-d (23) 23
gene (22) 22
magnetic resonance imaging (22) 22
metabolism (22) 22
phosphatonin (22) 22
article (21) 21
expression (21) 21
fibroblast growth factor (21) 21
osteomalacia - metabolism (21) 21
pathology (21) 21
rheumatology (21) 21
growth-factor 23 (20) 20
mutation (20) 20
pex gene (20) 20
secondary hyperparathyroidism (20) 20
urologic and male genital diseases (20) 20
in-vivo (19) 19
linked hypophosphatemic rickets (19) 19
tumor induced osteomalacia (19) 19
analysis (18) 18
d-resistant rickets (18) 18
fractures (18) 18
mesenchymoma - complications (18) 18
neoplasms, connective tissue - complications (18) 18
neoplasms, connective tissue - pathology (18) 18
of-the-literature (18) 18
pain (18) 18
paraneoplastic syndromes - etiology (18) 18
phex phosphate regulating neutral endopeptidase (18) 18
phosphaturic mesenchymal tumors (18) 18
endocrinology (17) 17
frizzled-related protein-4 (17) 17
immunohistochemistry (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (386) 386
Spanish (9) 9
German (8) 8
French (5) 5
Japanese (3) 3
Korean (2) 2
Czech (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


QJM: An International Journal of Medicine, ISSN 1460-2725, 06/2018, Volume 111, Issue 6, pp. 421 - 422
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2014, Volume 99, Issue 12, pp. 4403 - 4407
Journal Article
Bone Reports, ISSN 2352-1872, 12/2017, Volume 7, Issue C, pp. 90 - 97
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome clinically characterized by bone pain, fractures and muscle weakness. It is caused by... 
Tumor-induced osteomalacia | FGF23 | Phosphaturic mesenchymal tumors
Journal Article
Journal Article
Journal Article
AKTUELLE RHEUMATOLOGIE, ISSN 0341-051X, 06/2017, Volume 42, Issue 3, pp. 228 - 232
Osteomalacia is a rare disorder of bone metabolism associated with reduced bone mineralisation. The most common causes of this disease are vitamin D deficiency... 
osteomalacia | tumour-induced osteomalacia (TIO) | IMMIGRANTS | vitamin D | TUMOR-INDUCED OSTEOMALACIA | SECONDARY HYPERPARATHYROIDISM | PREVALENCE | HEALTH | RHEUMATOLOGY | EPIDEMIC | rickets | VITAMIN-D DEFICIENCY
Journal Article
by Li, Y and Li, YT and Hui, M and Liu, Y and Liu, XD and Jin, J and Gao, P
MEDICINE, ISSN 0025-7974, 03/2019, Volume 98, Issue 11, pp. e14846 - e14846
Tumor-induced osteomalacia (TIO) is a rare disease that behaves benignly. Very few reports about the features of the responsible tumors according to anatomical... 
LOCALIZATION | DIAGNOSIS | KI-67 PROTEIN | femur | surgical treatment | PROPOSAL | MEDICINE, GENERAL & INTERNAL | HYPOPHOSPHATEMIC OSTEOMALACIA | METABOLISM | tibia | FIBROBLAST GROWTH FACTOR-23 | ankle | foot | tumor-induced osteomalacia | Complications and side effects | Care and treatment | Extremities, Lower | Causes of | Osteomalacia | Health aspects | Tumors | Leg | Index Medicus | Abridged Index Medicus
Journal Article
ZEITSCHRIFT FUR RHEUMATOLOGIE, ISSN 0340-1855, 10/2018, Volume 77, Issue 8, pp. 703 - 718
ZusammenfassungUnter einer Osteomalazie versteht man eine Knochenerkrankung, die mit einer Storung der Skelettmineralisation einhergeht. Es wird eine... 
VITAMIN-D | Laborparameter | Laboratory parameters | Bildgebung | TUMOR-INDUCED OSTEOMALACIA | RHEUMATOLOGY | ONCOGENIC OSTEOMALACIA | Hypophosphatamie | Hypokalziamie | METABOLISM | Imaging | Hypophosphatemia | HEALTH | VitaminD | Hypocalcemia | EPIDEMIOLOGY | Index Medicus
Journal Article
Actualizaciones en Osteologia, ISSN 1669-8975, 2013, Volume 9, Issue 2, pp. 194 - 202
Journal Article
Osteoporosis International, ISSN 0937-941X, 7/2017, Volume 28, Issue 7, pp. 2187 - 2193
The majority of tumor-induced osteomalacia cases have been reported in the Northern Hemisphere and Asia. In this first series of South American patients, we... 
68 Ga PET/CT | Tumor-induced osteomalacia | Medicine & Public Health | Orthopedics | Rheumatology | Hypophosphatemia | Osteomalacia | FGF23 | Endocrinology | Ga PET/CT | LOCALIZATION | DIAGNOSIS | X-LINKED HYPOPHOSPHATEMIA | FIBROBLAST-GROWTH-FACTOR-23 | GA-68 DOTATATE PET/CT | Ga-68 PET/CT | ONCOGENIC OSTEOMALACIA | SERUM PHOSPHORUS | ENDOCRINOLOGY & METABOLISM | PATIENT | HEMANGIOPERICYTOMA | Neoplasms, Connective Tissue - diagnosis | Hypophosphatemia - etiology | Soft Tissue Neoplasms - diagnosis | Humans | Middle Aged | Male | Paraneoplastic Syndromes - diagnosis | Organometallic Compounds | Young Adult | Soft Tissue Neoplasms - complications | Soft Tissue Neoplasms - surgery | Paraneoplastic Syndromes - surgery | Adult | Female | Retrospective Studies | Bone Neoplasms - diagnosis | Octreotide - analogs & derivatives | Fractures, Spontaneous - diagnostic imaging | Fractures, Spontaneous - etiology | Neoplasms, Connective Tissue - surgery | Bone Neoplasms - complications | Bone Neoplasms - surgery | Paraneoplastic Syndromes - etiology | Biomarkers, Tumor - blood | Neoplasms, Connective Tissue - complications | Positron Emission Tomography Computed Tomography | Magnetic Resonance Imaging | Fibroblast Growth Factors - blood | Complications and side effects | Care and treatment | Research | Diagnosis | Risk factors | Tumors | Fibroblast growth factor | Mesenchyme | Fibroblast growth factor 23 | Reabsorption | Glomerular filtration rate | Fractures | Histopathology | Pain | Computed tomography | Sinus | Fibroblasts | Somatostatin | Localization | Growth factors | Enzyme-linked immunosorbent assay | Index Medicus
Journal Article
Journal Article
Osteoporosis International, ISSN 0937-941X, 4/2018, Volume 29, Issue 4, pp. 993 - 997
Journal Article
Journal Article